Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00663819 · ClinicalTrials.gov registry record · NA

Bioabsorbable Staple Line Reinforcement in Colorectal,Coloanal and Ileoanal Anastomoses

A NA study, sponsored by W.L.Gore & Associates.

Terminated
Registry status
NA
Development phase
258
Enrollment target

NCT00663819: Clinical Trial NA study, sponsored by W.L.Gore & Associates.

NCT00663819 is a NA study that was terminated before completion, run by W.L.Gore & Associates. The registered enrollment target is 258 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00663819, a NA study, was terminated before completion, sponsored by W.L.Gore & Associates.

TERMINATED
Registry status
NA
Development phase
258 participants
Enrollment target

Study Summary

The primary purpose of this prospective, randomized multicenter center study is to evaluate and compare the outcomes of colorectal, coloanal and ileoanal anastomoses reinforced with a bioabsorbable staple line reinforcement material compared with standard non-reinforced colorectal, coloanal and ileoanal techniques with respect to the incidence of postoperative anastomotic leakage, anastomotic stricture and time to ileostomy closure, if applicable.

Primary Outcome

The primary endpoint for the study is the proportion of subjects who experience a clinical and/or radiologic anastomotic leak through 4 - 12 weeks post procedure.

Interventions

  • DEVICE GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement
  • PROCEDURE Staple line without reinforcement

Trial Details

FieldValue
Enrollment Target 258 participants
Start Date 2008-04
Est. Completion 2012-10
Phase NA
W.L.Gore & Associates

53 total trials

Why NCT00663819 stopped before completion

NCT00663819 is an interventional study that assigns participants to a tested intervention. The registered 258 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).

The record links to 0 conditions, and to 2 interventions - of which GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement is the first listed.

NCT00663819 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00663819 about?

NCT00663819 is a clinical study titled "Bioabsorbable Staple Line Reinforcement in Colorectal,Coloanal and Ileoanal Anastomoses". The primary purpose of this prospective, randomized multicenter center study is to evaluate and compare the outcomes of colorectal, coloanal and ileoanal anastomoses reinforced with a bioabsorbable staple line reinforcement material compared with standard non-reinforced colorectal, coloanal and ileo...

What is the current status of trial NCT00663819?

This trial is currently terminated. It is a NA study. The enrollment target is 258 participants. The study started on 2008-04. Estimated completion is 2012-10.

What interventions are being tested in trial NCT00663819?

The interventions under investigation include: GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement (DEVICE), Staple line without reinforcement (PROCEDURE).

Who is sponsoring clinical trial NCT00663819?

This trial is sponsored by W.L.Gore & Associates, which has 53 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00663819's enrollment target sits among peer trials

258 402nd of 2000 higher than 1,598 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03785288 · 258 participants · Phase 3

    Vaginal Cuff Brachytherapy Fractionation Study

  • NCT04643002 · 258 participants · Phase 1

    Isatuximab in Combination With Novel Agents in RRMM - Master Protocol

  • NCT04924322 · 258 participants · Phase 2

    Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies

  • NCT05043012 · 258 participants · NA

    Diagnostic Performance Of Non-Endorectal Coil Multiparametric Magnetic Resonance Imaging Of Prostate With Flexible AIR Coil (DoNEMAC Study)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00663819, the US trial registry maintained by the National Library of Medicine. NCT00663819 (mid enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.